CYPRadarCYPRadar

Cyprus launches reimbursement for Mounjaro obesity treatment under Gesy with strict eligibility criteria

Starting October 15, adults in Cyprus qualifying for obesity treatment under Gesy can access reimbursement for Mounjaro injections, a medication also used for Type 2 diabetes. To qualify, patients must have a BMI of at least 40 or between 35 and 40 with specific health conditions such as cardiovascular disease or obstructive sleep apnea. Approval requires meeting medical criteria and prior authorization, with initial dispensing only through state hospital pharmacies.

Mounjaro and Ozempic, both weekly injectable medications, differ in their modes of action and patient responses, with Mounjaro potentially offering greater weight loss for some. However, side effects such as gastrointestinal symptoms are common, and medical supervision is essential. Specialists are responsible for issuing prescriptions, and treatment may be reimbursed for up to two years, contingent on ongoing eligibility.

Medical experts emphasize that these medications are not substitutes for healthy lifestyle changes, and patients should work closely with healthcare providers to manage expectations, monitor side effects, and maintain progress. The new Gesy rules aim to increase accessibility, but underscore the importance of comprehensive patient support and individualized treatment plans.

CYPRadar is a state-of-the-art, AI-powered Cyprus news aggregator that automatically crawls, filters, and translates local updates in real time. By continuously scanning a wide range of trusted Cypriot media outlets, blogs, and official RSS feeds, the platform identifies original stories and uses advanced language models to filter out duplicate coverage. The service then generates concise, objective summaries, ensuring that readers get a quick and clear understanding of every significant event without information overload.

The primary mission of CYPRadar is to provide comprehensive, multi-language coverage of Cyprus news to keep both residents and international visitors well-informed. The platform covers key events across all major cities and districts, including Nicosia, Limassol, Larnaca, Paphos, and Famagusta. By offering all updates simultaneously in five languages — English, Russian, Greek, Ukrainian, and Turkish — CYPRadar bridges communication gaps and ensures that everyone has equal access to critical local information, from policy changes to community events.

Access vital health and medical updates in Cyprus. Stay informed about the Gesy national health system, hospital services, public health campaigns, updates on duty pharmacies, pharmaceutical news, and wellness advice.